Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

2articles mentioning drugs

11drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: rhIL-15 ×

rhIL-15

This drug is selected. Its supporting articles are shown below.

Articles mentioning rhIL-15

2 articles · page 1 of 1

Phase 1 study evaluating the safety, preliminary efficacy, and pharmacodynamics of recombinant interleukin-15 in combination with nivolumab and ipilimumab in patients with refractory cancers

jitc · abstract · 2025-12-21 · 8 matching annotations

95.0%

nivolumab ipilimumab rhIL-15

…mab in safety run-in cohorts, 26 patients received rhIL-15 with nivolumab plus ipilimumab. The most common cancer types were gastrointest…

521 Correlative analysis of a phase I study of autologous activated NK Cells ± rhIL-15 in children and young adults with refractory solid tumors

jitc · abstract · 2025-11-04 · 3 matching annotations

94.1%

rhIL-15 cyclophosphamide National Cancer Institute solid tumors relapsed/refractory solid tumors NK cell immunotherapies NCI

…lophosphamide without (Cohort A) and with (Cohort B) continuous rhIL-15 infusion. Correlative studies included spectral flow cytometry,…